Drug Approval | November 18, 2021
Zydus Cadila receives U.S.FDA approval for leukaemia injection
Nelarabine is in a class of medications called antimetabolites
Nelarabine is in a class of medications called antimetabolites
It is anticipated to be safe and efficacious by targeting the receptor-binding domain (RBD) of the new coronavirus
A CRISIL study of 207 pharmaceutical companies that account for 55% of the Rs 3.2 lakh crore-a-year sector revenue indicates as much.
It is India’s first pneumotach based portable wireless Spirometer for diagnosis of Chronic Obstructive Pulmonary Disorder (COPD)
Launching in 2022, its availability will be expanded to the global market
The initiative will engage adolescents and youth of India in decisions about their reproductive health
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
The interim data combines three mRNAs into one therapy injected directly into the tumour
Data demonstrates Ronapreve reduced risk of hospitalisation in certain patients and reduced risk of symptomatic Covid-19 infections in people exposed to the virus
A final decision regarding the approval of Ronapreve is expected from the European Commission shortly
Subscribe To Our Newsletter & Stay Updated
